A pH-eQTL Interaction at the
Parkinson’s disease
RIT2
SYT4
eQTL analysis
gene expression
pH
rs12456492
substantia nigra (SN)
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
04
2021
accepted:
14
06
2021
entrez:
26
7
2021
pubmed:
27
7
2021
medline:
27
7
2021
Statut:
epublish
Résumé
Parkinson's disease causes severe motor and cognitive disabilities that result from the progressive loss of dopamine neurons in the substantia nigra. The rs12456492 variant in the
Identifiants
pubmed: 34305570
doi: 10.3389/fnagi.2021.690632
pmc: PMC8299340
doi:
Types de publication
Journal Article
Langues
eng
Pagination
690632Informations de copyright
Copyright © 2021 Patel, Howard and French.
Déclaration de conflit d'intérêts
LF owns shares in and has received consulting fees from Cortexyme Inc., a company that is developing gingipain inhibitors to treat neurodegenerative diseases. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2014 Dec 10;9(12):e115029
pubmed: 25493648
Gene. 2020 Mar 20;731:144349
pubmed: 31935499
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Clin Med Insights Case Rep. 2010;3:9-13
pubmed: 21769248
Nat Neurosci. 2009 Jun;12(6):767-76
pubmed: 19448629
J Mol Biol. 2009 Apr 3;387(3):771-85
pubmed: 19361420
Sci Rep. 2017 Jul 14;7(1):5435
pubmed: 28710439
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
FEBS Lett. 2013 Jun 27;587(13):1923-8
pubmed: 23669358
Nat Neurosci. 2014 Oct;17(10):1418-1428
pubmed: 25174004
Sci Transl Med. 2010 Oct 6;2(52):52ra73
pubmed: 20926834
Biopolymers. 2016 Oct;105(10):715-24
pubmed: 27177831
J Neurochem. 2011 Oct;119(2):275-82
pubmed: 21848658
Mov Disord. 2020 Mar;35(3):504-507
pubmed: 31898835
FEBS Lett. 1996 Dec 2;398(2-3):322-5
pubmed: 8977131
Neurobiol Dis. 2016 Feb;86:29-40
pubmed: 26581638
Arch Immunol Ther Exp (Warsz). 1999;47(2):89-98
pubmed: 10202561
Aging (Albany NY). 2016 Oct 10;8(10):2425-2436
pubmed: 27743511
Front Neurosci. 2018 Nov 26;12:859
pubmed: 30534046
Lancet Neurol. 2019 Dec;18(12):1091-1102
pubmed: 31701892
Bioorg Med Chem Lett. 2013 Jan 1;23(1):256-60
pubmed: 23200251
Ann Neurol. 2012 Mar;71(3):370-84
pubmed: 22451204
Kidney Int. 2008 Jan;73(2):226-32
pubmed: 17978815
J Biol Chem. 2011 Jul 8;286(27):23928-37
pubmed: 21576241
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9103-8
pubmed: 15181200
J Mol Biol. 2018 Aug 3;430(16):2360-2371
pubmed: 29782835
J Neurosci. 1996 Nov 1;16(21):6784-94
pubmed: 8824319
Biochem Biophys Res Commun. 2001 Nov 2;288(3):666-9
pubmed: 11676494
J Biol Chem. 2017 Sep 29;292(39):16368-16379
pubmed: 28710275
Database (Oxford). 2021 Feb 18;2021:
pubmed: 33599246
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1253-E1262
pubmed: 28154140
PLoS Genet. 2011 Jun;7(6):e1002141
pubmed: 21738487
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Parkinsonism Relat Disord. 2016 Feb;23:1-9
pubmed: 26739246
Aging Cell. 2018 Aug;17(4):e12787
pubmed: 29873184
Nat Genet. 2017 Oct;49(10):1511-1516
pubmed: 28892059
Neuroscience. 2010 May 5;167(2):384-95
pubmed: 20138973
J Alzheimers Dis. 2010;20 Suppl 1:S221-38
pubmed: 20182023
J Neurosci. 2011 Sep 28;31(39):13758-70
pubmed: 21957239
Neurobiol Dis. 2008 Sep;31(3):334-41
pubmed: 18606547
Brain. 2004 Feb;127(Pt 2):420-30
pubmed: 14662519
Biology (Basel). 2019 May 11;8(2):
pubmed: 31083583
Eur J Neurosci. 2006 Feb;23(4):1077-81
pubmed: 16519673
Front Mol Neurosci. 2018 Dec 18;11:467
pubmed: 30618616
J Pathol. 2007 Dec;213(4):369-75
pubmed: 17990279
Nat Neurosci. 2011 Jun;14(6):694-6
pubmed: 21572432
NPJ Parkinsons Dis. 2018 Jul 10;4:21
pubmed: 30003140